Gothamist
A non-profit newsroom, powered by WNYC.
Gothamist
Listen Live
News
Candidate Giuliani's Drug (Consulting) Problem
By
Dave Hogarty
Published Dec 29, 2007
Modified Mar 7, 2008
Share
FacebookTwitterRedditEmail
Never miss a story
Email address
By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .
By
Dave Hogarty
Published Dec 29, 2007
Modified Mar 7, 2008
Share
FacebookTwitterRedditEmail
We rely on your support to make local news available to all
Make your contribution now and help Gothamist thrive in 2026. Donate today
Gothamist is funded by sponsors and member donations
Rudy Giuliani's good financial fortune derived from the formation of Giuliani Partners is leading to political misfortune, as yet another piece of lucrative business he conducted in the private sector has come back to haunt his candidacy. Recently, his involvement with Purdue Pharma--the producers of the painkiller OxyContin--has come under scrutiny.
Giuliani is being accused of using his high profile in the wake of 9/11, his background as a federal prosecutor, and his personal reputation in order to run interference against law enforcement for a drug company that was paying him handsomely. The top executives of Purdue Pharma eventually pleaded guilty to criminal charges for insufficiently warning the public of the potential for abuse of its highly profitable product as a street drug, and the company paid more than $600 million in fines.
Giuliani apparently found it very profitable to straddle the divide between government and his client, meeting with Asa Hutchinson, who was then the head of the DEA, after the agency began an investigation into Purdue. He stressed his credibility on the issue of fighting drug abuse by mentioning that he had donated $15,000 to the funding of a traveling DEA museum. He also assured Hutchinson that he was sending one of his top associates to oversee security improvements at Purdue's plant in New Jersey. Giuliani sent Bernard Kerik, who has proved to be a continuing embarrassment to his campaign.
Earlier this year, The Washington Post reported that while Giuliani was attempting to politically protect his client as OxyContin abuse was becoming a growing problem, the Justice Department was paying his firm $1.1 million to conduct a management review of the department's organized crime drug task force. One of that task force's responsibilities was to stem the illegal trade in OxyContin as a recreational narcotic.
(Image from ABC News blog The Blotter)
Tagged
abc
abc news
Asa Hutchinson
Bernard Kerik
dea
giuliani
Giuliani Partners
justice department
law enforcement
new jersey
news
oxycontin
rudy giuliani
The Washington
The Washington Post
washington
washington post
Dave Hogarty
Read more
Gothamist is funded by sponsors and member donations
Gothamist is funded by sponsors and member donations
MORE news
NYPD says man murdered his elderly aunt at their Bronx home
The man, 35, was charged with murder and assault.
By
Catalina Gonella
Published Nov 15, 2026 at 8:18 p.m. ET
A DJ survived the Brooklyn building collapse: His prized record collection did not
Omari Jack lost a massive collection of reggae records and memorabilia.
By
Michael Sol Warren
News
A DJ survived the Brooklyn building collapse: His prized record collection did not
Omari Jack lost a massive collection of reggae records and memorabilia.
By
Michael Sol Warren
New York's biggest trash dump is releasing even more methane than thought
By
Rosemary Misdary
NYPD fatally shoots driver on Belt Parkway following suspected kidnapping
By
Michael Sol Warren
Some in NY fret about being hit by the AI bus. Others are trying to board it.
By
Willow Higgins
Never miss a story
Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.
Sign upEmail address
By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .